The author provides an overview of literature pertaining to the complex and specialist subject of biofilms that may occur in aesthetic medicine. A brief overview is presented concerning the pathophysiology of biofilms with some discussion concerning differential presentations; early and delayed onset of inflammatory nodules, abscess formation as well as granulomatous responses. The importance of the histological confirmation of the diagnosis of a true granuloma is not discussed, yet the treatment recommendations are outlined. Some risk factors are mentioned for dermal filler treatments, including the importance of strict asepsis throughout all dermal filler procedures. In light of the subject, there is little discussion concerning appropriate skin cleansing agents, or evidence for specific recommendations. A greater emphasis could have been placed on the importance of timely referral for specialist assessment and diagnosis. This is important given the complex nature of such presentations and the potential for misdiagnosis. To adhere to best practice it may have been prudent to briefly remind readers of the importance of appropriate Medicines and Healthcare Products Regulatory Agency (MHRA) yellow card reporting of adverse events and serious complications. This is an insightful article which reinforces the importance of some of the associated risks for aesthetic nurses undertaking a variety of dermal filler treatments.
The role of bacterial biofilms in aesthetic medicine prioritising prevention
Reviewed by Anna Baker
The role of bacterial biofilms in aesthetic medicine: prioritizing prevention.
